246 related articles for article (PubMed ID: 12463121)
1. [Seminal vesicle invasion afer radical prostatectomy: study of risk factors for progression].
Salomon L; Levrel O; de la Taille A; Hoznek A; Chopin D; Abbou CC
Prog Urol; 2002 Sep; 12(4):621-7. PubMed ID: 12463121
[TBL] [Abstract][Full Text] [Related]
2. Contemporary survival results and the role of radiation therapy in patients with node negative seminal vesicle invasion following radical prostatectomy.
Eggener SE; Roehl KA; Smith ND; Antenor JA; Han M; Catalona WJ
J Urol; 2005 Apr; 173(4):1150-5. PubMed ID: 15758725
[TBL] [Abstract][Full Text] [Related]
3. Does the tertiary Gleason pattern influence the PSA progression-free interval after retropubic radical prostatectomy for organ-confined prostate cancer?
van Oort IM; Schout BM; Kiemeney LA; Hulsbergen CA; Witjes JA
Eur Urol; 2005 Oct; 48(4):572-6. PubMed ID: 16046051
[TBL] [Abstract][Full Text] [Related]
4. Predictors of prostate-specific antigen progression among men with seminal vesicle invasion at the time of radical prostatectomy.
Freedland SJ; Aronson WJ; Presti JC; Amling CL; Terris MK; Trock B; Kane CJ
Cancer; 2004 Apr; 100(8):1633-8. PubMed ID: 15073850
[TBL] [Abstract][Full Text] [Related]
5. Prognostic indicators for long term outcome following radical retropubic prostatectomy for prostate cancer involving the seminal vesicles.
Johnson CW; Anastasiadis AG; McKiernan JM; Salomon L; Eaton S; Goluboff ET; Olsson CA; Benson MC
Urol Oncol; 2004; 22(2):107-11. PubMed ID: 15082006
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of patients with prostate cancer and pathologic seminal vesicle invasion (pT3b): effect of adjuvant radiotherapy.
Lee HM; Solan MJ; Lupinacci P; Gomella LG; Valicenti RK
Urology; 2004 Jul; 64(1):84-9. PubMed ID: 15245941
[TBL] [Abstract][Full Text] [Related]
7. Isolated seminal vesicle invasion imparts better outcomes after radical retropubic prostatectomy for clinically localized prostate cancer: prognostic stratification of pt3b disease by nodal and margin status.
Masterson TA; Pettus JA; Middleton RG; Stephenson RA
Urology; 2005 Jul; 66(1):152-5. PubMed ID: 15992904
[TBL] [Abstract][Full Text] [Related]
8. An analysis of risk factors for biochemical progression in patients with seminal vesicle invasion: validation of Kattan's nomogram in a pathological subgroup.
Ramsden AR; Chodak G
BJU Int; 2004 May; 93(7):961-4. PubMed ID: 15142143
[TBL] [Abstract][Full Text] [Related]
9. Invasion of seminal vesicles by adenocarcinoma of the prostate: PSA outcome determined by preoperative and postoperative factors.
Bloom KD; Richie JP; Schultz D; Renshaw A; Saegaert T; D'amico AV
Urology; 2004 Feb; 63(2):333-6. PubMed ID: 14972484
[TBL] [Abstract][Full Text] [Related]
10. Is seminal vesicle ablation mandatory for all patients undergoing radical prostatectomy? A multivariate analysis on 1283 patients.
Zlotta AR; Roumeguère T; Ravery V; Hoffmann P; Montorsi F; Türkeri L; Dobrovrits M; Scattoni V; Ekane S; Bollens R; Vanden Bossche M; Djavan B; Boccon-Gibod L; Schulman CC;
Eur Urol; 2004 Jul; 46(1):42-9. PubMed ID: 15183546
[TBL] [Abstract][Full Text] [Related]
11. After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancer.
Sengupta S; Blute ML; Bagniewski SM; Inman B; Leibovich BC; Slezak JM; Myers RP; Zincke H
BJU Int; 2008 Jan; 101(2):170-4. PubMed ID: 18173824
[TBL] [Abstract][Full Text] [Related]
12. [Survival after radical prostatectomy in patients with prostate cancer and seminal vesicle invasion].
Castillejos-Molina RA; Rodríguez-Covarrubias F; Sotomayor de Zavaleta M; Uribe-Uribe N; Lino LS; Feria-Bernal G
Rev Invest Clin; 2008; 60(5):360-4. PubMed ID: 19227432
[TBL] [Abstract][Full Text] [Related]
13. Importance of margin extent as a predictor of outcome after adjuvant radiotherapy for Gleason score 7 pT3N0 prostate cancer.
Valicenti RK; Chervoneva I; Gomella LG
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1093-7. PubMed ID: 15001249
[TBL] [Abstract][Full Text] [Related]
14. [Improvement over time of oncological results after radical prostatectomy: what are the responsible factors?].
Salomon L; Herard A; Colombel M; Patard JJ; Bellot J; Lefrere-Belda MA; Hoznék A; Gasman D; Chopin D; Abbou CC
Prog Urol; 1998 Jun; 8(3):363-9. PubMed ID: 9689668
[TBL] [Abstract][Full Text] [Related]
15. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
[TBL] [Abstract][Full Text] [Related]
16. [Role of biological and anatomo-pathologic criteria in the prognosis evaluation of patients before and after radical prostatectomy].
Ravery V; Boccon-Gibod LA; Dauge-Geffroy MC; Billebaud T; Meulemans A; Toublanc M; Delmas V; Boccon-Gibod L
Prog Urol; 1994 Oct; 4(5):673-82. PubMed ID: 7532070
[TBL] [Abstract][Full Text] [Related]
17. Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database.
Freedland SJ; Aronson WJ; Terris MK; Kane CJ; Amling CL; Dorey F; Presti JC;
J Urol; 2003 Jun; 169(6):2136-41. PubMed ID: 12771735
[TBL] [Abstract][Full Text] [Related]
18. Vascular invasion predicts recurrence after radical prostatectomy: stratification of risk based on pathologic variables.
Ferrari MK; McNeal JE; Malhotra SM; Brooks JD
Urology; 2004 Oct; 64(4):749-53. PubMed ID: 15491714
[TBL] [Abstract][Full Text] [Related]
19. [Current value of seminal vesicle biopsy in patients with prostate cancer and influence of radical prostatectomy in patients with seminal vesicle invasion].
Losa CA; Fernando AB; Lázaro VA; Berlanga FF; Frago PS; López MA; Sanz MJ; Martínez PG; Sanz LA
Arch Esp Urol; 2006 Dec; 59(10):977-88. PubMed ID: 17283711
[TBL] [Abstract][Full Text] [Related]
20. Seminal vesicle involvement after radical prostatectomy: predicting risk factors for progression.
Salomon L; Anastasiadis AG; Johnson CW; McKiernan JM; Goluboff ET; Abbou CC; Olsson CA; Benson MC
Urology; 2003 Aug; 62(2):304-9. PubMed ID: 12893340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
